Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients

AIM: To compare the outcomes of GDPT [gemcitabine (G), cisplatin (D), prednisone (P), thalidomide (T)] versus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) in treating newly diagnosed PTCL (peripheral T-cell lymphoma). METHODS: An open-label prospective clinical trial with 153 newly...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yuanyuan, Li, Ling, Li, Xin, Zhang, Lei, Wang, Xinhua, Fu, Xiaorui, Sun, Zhenchang, Zhang, Xudong, Li, Zhaoming, Wu, Jingjing, Yu, Hui, Chang, Yu, Yan, Jiaqin, Wu, Xiaolong, Zhou, Zhiyuan, Nan, Feifei, Tian, Li, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278096/
https://www.ncbi.nlm.nih.gov/pubmed/32550864
http://dx.doi.org/10.1177/1758835920923829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278096/
https://www.ncbi.nlm.nih.gov/pubmed/32550864
http://dx.doi.org/10.1177/1758835920923829

Ejemplares similares